Research suggests that DMT may not be the only compound responsible for ayahuasca's effects.
Research indicates that C-Reactive Protein may play a vital role in combating Treatment-Resistant Depression.
The Mental Organs Hypothesis reconsiders the relationship between 5-HT2 receptors and the qualitative effects of psychedelics.
This compound exhibits reduced cardiotoxicity, psychoplastogen characteristics, and potential therapeutic effects in animal models.
Researchers at the forefront of psychedelic science put forth their arguments in this important debate.
This study provides meaningful access to some lesser-known magic mushroom compounds and conducts biological testing on them for the first time.
The characterization of methoxetamine, a ketamine analog, and how its action on the serotonin system sets it apart.
Brain imaging research reveals where psychedelic compounds such as psilocybin and LSD manifest their effects.
There is much research into psychedelic treatment of mental disorders, but psychedelics might be effective in treating autoimmune disorders as well.
The monoamine hypothesis of depression leaves many patients without effective help. It’s time for a paradigm shift, and psychedelics may be leading the way.